TELA Bio, Inc. Unamortized Debt Issuance Expense
TELA Bio, Inc. (TELA) had Unamortized Debt Issuance Expense of $3.92 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2026-08-11
- 2026-06-30: Unamortized Debt Issuance Expense $3.92M.
- 2026-03-31: Unamortized Debt Issuance Expense $4.13M.
- 2025-12-31: Unamortized Debt Issuance Expense $4.35M.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2026-06-30 | $3.92M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $4.13M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $4.35M 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |